The global pharmaceutical sector is witnessing an unprecedented surge in demand for Anti-inflammatory drugs. As chronic inflammatory diseases, autoimmune disorders, and geriatric health challenges become more prevalent, the role of manufacturers and exporters has shifted from simple supply to strategic partnership. Currently, the market is valued at billions of dollars, with Non-Steroidal Anti-inflammatory Drugs (NSAIDs) leading the volume.
Technological integration in API (Active Pharmaceutical Ingredient) production has allowed for higher purity and better bioavailability. For global procurement officers, the focus has shifted toward finding manufacturers that offer not just competitive pricing, but robust GMP compliance and sustainable supply chains.
The anti-inflammatory drug industry is currently defined by three major trends: Molecular Precision, Automation, and Sustainability. Artificial Intelligence is now used to predict drug-protein interactions, reducing the time-to-market for pharmaceutical intermediates. For exporters, this means the ability to offer more refined chemical profiles that meet the strict localized standards of Europe, North America, and Southeast Asia.
In the veterinary sector, anti-inflammatory drugs are essential for livestock welfare and pet longevity. Our specialized formulations, like Firocoxib, target pain management specifically for canine and equine patients, ensuring rapid recovery without the gastrointestinal side effects common in older drug generations. As a leading exporter, we ensure our veterinary line adheres to the same stringent quality controls as human-grade pharmaceuticals.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Our drugs and intermediates are widely used across multiple high-tech industries:
As a core part of our export portfolio, Flunixin Meglumine represents the pinnacle of non-steroidal anti-inflammatory power for large animals. Our manufacturing process utilizes high-efficiency batch reactors to ensure consistent concentration and sterility. For international buyers, we provide full technical dossiers and COA (Certificate of Analysis) to simplify the local registration process.
We understand localized application scenarios, from heat-stress inflammation in tropical livestock to post-surgical recovery in European veterinary clinics.
Streamlined logistics and flexible payment terms for global enterprises, ensuring your supply chain remains uninterrupted.
We provide advanced manufacturing capabilities including batch processing and specific chemical customization for unique industrial needs.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
SJ medical
